Cargando…

Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions

The safety and efficacy of kratom (Mitragyna speciosa) for treatment of pain is highly controversial. Kratom produces more than 40 structurally related alkaloids, but most studies have focused on just two of these, mitragynine and 7-hydroxymitragynine. Here, we profiled 53 commercial kratom products...

Descripción completa

Detalles Bibliográficos
Autores principales:	Todd, D. A., Kellogg, J. J., Wallace, E. D., Khin, M., Flores-Bocanegra, L., Tanna, R. S., McIntosh, S., Raja, H. A., Graf, T. N., Hemby, S. E., Paine, M. F., Oberlies, N. H., Cech, N. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645423/ https://www.ncbi.nlm.nih.gov/pubmed/33154449 http://dx.doi.org/10.1038/s41598-020-76119-w

Ejemplares similares

Kratom ( Mitragyna speciosa ) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products
por: Manwill, Preston K., et al.
Publicado: (2022)

Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
por: Tanna, Rakshit S., et al.
Publicado: (2022)

Kratom (Mitragyna speciosa)-Induced Hepatitis
por: Allison, Devin R., et al.
Publicado: (2022)

A Case of Hyperkalemia Induced by Kratom (Mitragyna speciosa)
por: Torres-Ortiz, Aldo, et al.
Publicado: (2022)

Association between kratom (Mitragyna speciosa) use and metabolic syndrome
por: La-up, Aroon, et al.
Publicado: (2022)

Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom)
por: Zhang, Mengzi, et al.
Publicado: (2020)

Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
por: Prevete, Elisabeth, et al.
Publicado: (2023)

Kratom (Mitragyna speciosa) and COVID-19: How about the current evidence?
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Lipid profile of regular kratom (Mitragyna speciosa Korth.) users in the community setting
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2020)

Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand
por: Leksungnoen, Nisa, et al.
Publicado: (2022)

Investigating the Impact of Kratom (Mitragyna speciosa) Use Upon Male Sexual Health
por: Deebel, Nicholas A, et al.
Publicado: (2023)

Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use
por: Singh, Darshan, et al.
Publicado: (2020)

Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
por: Ng, Jeremy Y., et al.
Publicado: (2021)

The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
por: Metastasio, Antonio, et al.
Publicado: (2020)

Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review
por: Striley, Catherine W, et al.
Publicado: (2022)

Assessment of the possible health risks associated with the consumption of botanical preparations of Mitragyna speciosa (kratom)
por: Papadi, Georgia, et al.
Publicado: (2022)

The Mitragyna speciosa (Kratom) Genome: a resource for data-mining potent pharmaceuticals that impact human health
por: Brose, Julia, et al.
Publicado: (2021)

Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance
por: Zhang, Mengzi, et al.
Publicado: (2022)

Inhibition of α-Glucosidase and Pancreatic Lipase Properties of Mitragyna speciosa (Korth.) Havil. (Kratom) Leaves
por: Limcharoen, Thanchanok, et al.
Publicado: (2022)

Seasonal and Geographic Variation in Alkaloid Content of Kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand
por: Sengnon, Narumon, et al.
Publicado: (2023)

Translating Kratom-Drug Interactions: From Bedside to Bench and Back
por: Tanna, Rakshit S., et al.
Publicado: (2023)

Assessment of Cardiovascular Functioning Among Regular Kratom (Mitragyna speciosa Korth) Users: A Case Series
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

A Chromosome-Scale Genome Assembly of Mitragyna speciosa (Kratom) and the Assessment of Its Genetic Diversity in Thailand
por: Pootakham, Wirulda, et al.
Publicado: (2022)

Accelerated Solvent Extractions (ASE) of Mitragyna speciosa Korth. (Kratom) Leaves: Evaluation of Its Cytotoxicity and Antinociceptive Activity
por: Goh, Yong Sean, et al.
Publicado: (2021)

Acute, Sublethal, and Developmental Toxicity of Kratom (Mitragyna speciosa Korth.) Leaf Preparations on Caenorhabditis elegans as an Invertebrate Model for Human Exposure
por: Hughes, Samantha, et al.
Publicado: (2022)

Exploring of cardiac autonomic activity with heart rate variability in long-term kratom (Mitragyna speciosa Korth.) users: a preliminary study
por: Saengmolee, Wanumaidah, et al.
Publicado: (2022)

Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom
por: Tanna, Rakshit S., et al.
Publicado: (2023)

First Report of Meloidogyne Incognita Infecting Mitragyna Speciosa in the United States
por: Habteweld, Alemayehu, et al.
Publicado: (2022)

Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
por: Cinosi, Eduardo, et al.
Publicado: (2015)

Metabolomics data of Mitragyna speciosa leaf using LC-ESI-TOF-MS
por: Veeramohan, Rubashiny, et al.
Publicado: (2018)

Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
por: Meireles, Vânia, et al.
Publicado: (2019)

Leaf Anatomy and Micromorphology Characteristics of Ketum [Mitragyna speciosa (Korth.) Havil.] (Rubiaceae)
por: Ghazalli, Mohd Norfaizal, et al.
Publicado: (2021)

Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention
por: Janthongkaw, Atikarn, et al.
Publicado: (2023)

Evaluation of the Effects of Mitragyna speciosa Alkaloid Extract on Cytochrome P450 Enzymes Using a High Throughput Assay
por: Kong, Wai Mun, et al.
Publicado: (2011)

Understanding the Physicochemical Properties of Mitragynine, a Principal Alkaloid of Mitragyna speciosa, for Preclinical Evaluation
por: Ramanathan, Surash, et al.
Publicado: (2015)

Differentiation of Mitragyna speciosa, a narcotic plant, from allied Mitragyna species using DNA barcoding-high-resolution melting (Bar-HRM) analysis
por: Tungphatthong, Chayapol, et al.
Publicado: (2021)

Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor System
por: Shamima, Abdul Rahman, et al.
Publicado: (2012)

Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats
por: Ilmie, Mohd U., et al.
Publicado: (2015)

The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa Korth leaves in rats
por: Sabetghadam, Azadeh, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tilfdsa1oe9agrqhsk70inigar